These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Elimination of malignant clonogenic T cells from human bone marrow using chemoimmunoseparation with 2'-deoxycoformycin, deoxyadenosine and an immunotoxin. Montgomery RB; Kurtzberg J; Rhinehardt-Clark A; Haleen A; Ramakrishnan S; Olsen GA; Peters WP; Smith CA; Haynes BF; Houston LL Bone Marrow Transplant; 1990 Jun; 5(6):395-402. PubMed ID: 2369680 [TBL] [Abstract][Full Text] [Related]
3. Immunotoxin-mediated elimination of clonogenic tumor cells in the presence of human bone marrow. Uckun FM; Ramakrishnan S; Houston LL J Immunol; 1985 Mar; 134(3):2010-6. PubMed ID: 3855433 [TBL] [Abstract][Full Text] [Related]
4. Combined ex vivo treatment with immunotoxins and mafosfamid: a novel immunochemotherapeutic approach for elimination of neoplastic T cells from autologous marrow grafts. Uckun FM; Stong RC; Youle RJ; Vallera DA J Immunol; 1985 May; 134(5):3504-15. PubMed ID: 3884712 [TBL] [Abstract][Full Text] [Related]
5. Cytotoxic activity of an anti-transferrin receptor immunotoxin on normal and leukemic human hematopoietic progenitors. Cazzola M; Bergamaschi G; Dezza L; D'Uva R; Ponchio L; Rosti V; Ascari E Cancer Res; 1991 Jan; 51(2):536-41. PubMed ID: 1985771 [TBL] [Abstract][Full Text] [Related]
6. In vivo anti-leukemic efficacy of anti-CD7-pokeweed antiviral protein immunotoxin against human T-lineage acute lymphoblastic leukemia/lymphoma in mice with severe combined immunodeficiency. Gunther R; Chelstrom LM; Finnegan D; Tuel-Ahlgren L; Irvin JD; Myers DE; Uckun FM Leukemia; 1993 Feb; 7(2):298-309. PubMed ID: 7678882 [TBL] [Abstract][Full Text] [Related]
7. Increased efficiency in selective elimination of leukemia cells by a combination of a stable derivative of cyclophosphamide and a human B-cell-specific immunotoxin containing pokeweed antiviral protein. Uckun FM; Ramakrishnan S; Houston LL Cancer Res; 1985 Jan; 45(1):69-75. PubMed ID: 3871174 [TBL] [Abstract][Full Text] [Related]
8. In vitro bone marrow purging of multidrug-resistant cells with a mouse monoclonal antibody directed against Mr 170,000 glycoprotein and a saporin-conjugated anti-mouse antibody. Dinota A; Tazzari PL; Michieli M; Visani G; Gobbi M; Bontadini A; Tassi C; Fanin R; Damiani D; Grandi M Cancer Res; 1990 Jul; 50(14):4291-4. PubMed ID: 1694719 [TBL] [Abstract][Full Text] [Related]
9. Effective immunochemotherapy of human t(4;11) leukemia in mice with severe combined immunodeficiency (SCID) using B43 (anti-CD19)-pokeweed antiviral protein immunotoxin plus cyclophosphamide. Jansen B; Kersey JH; Jaszcz WB; Gunther R; Nguyen DP; Chelstrom LM; Tuel-Ahlgren L; Uckun FM Leukemia; 1993 Feb; 7(2):290-7. PubMed ID: 7678881 [TBL] [Abstract][Full Text] [Related]
10. Specific ex-vivo depletion of human bone marrow T lymphocytes by an anti-pan-T cell (CD5) ricin A-chain immunotoxin. Siena S; Villa S; Bonadonna G; Bregni M; Gianni AM Transplantation; 1987 Mar; 43(3):421-6. PubMed ID: 3103275 [TBL] [Abstract][Full Text] [Related]
11. Elimination of clonogenic T-leukemic cells from human bone marrow using anti-Mr 65,000 protein immunotoxins. Stong RC; Youle RJ; Vallera DA Cancer Res; 1984 Jul; 44(7):3000-6. PubMed ID: 6372999 [TBL] [Abstract][Full Text] [Related]
12. Positive selection of hematopoietic CD34+ stem cells provides 'indirect purging' of CD34- lymphoid cells and the purging efficiency is increased by anti-CD2 and anti-CD30 immunotoxins. Lemoli RM; Tazzari PL; Fortuna A; Bolognesi A; Gulati SC; Stirpe F; Tura S Bone Marrow Transplant; 1994 Apr; 13(4):465-71. PubMed ID: 7517259 [TBL] [Abstract][Full Text] [Related]
13. Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain. Ramakrishnan S; Houston LL Cancer Res; 1984 Apr; 44(4):1398-404. PubMed ID: 6142765 [TBL] [Abstract][Full Text] [Related]
14. An immunotoxin system intended for bone marrow purging composed of glucose oxidase and lactoperoxidase coupled to monoclonal antibody 097. Ito HO; Morizet J; Coulombel L; Goavec M; Rousseau V; Bernard A; Stanislawski M Bone Marrow Transplant; 1989 Sep; 4(5):519-27. PubMed ID: 2790330 [TBL] [Abstract][Full Text] [Related]
15. Use of colony assays and anti-T cell immunotoxins to elucidate the immunobiologic features of leukemic progenitor cells in T-lineage acute lymphoblastic leukemia. Uckun FM; Myers DE; Ledbetter JA; Swaim SE; Gajl-Peczalska KJ; Vallera DA J Immunol; 1988 Mar; 140(6):2103-11. PubMed ID: 3126241 [TBL] [Abstract][Full Text] [Related]
16. T-cell depletion with ricin A-chain T101 in allogeneic bone marrow transplantation to prevent severe graft-versus-host disease. Fauser AA; Shustik C; Langleben A; Laurent G; Kanz L; Spurll GM; Price G; Ahlgren PD; Cooper BA Clin Invest Med; 1988 Feb; 11(1):40-6. PubMed ID: 3284672 [TBL] [Abstract][Full Text] [Related]
17. Immunotoxins show rapid entry of diphtheria toxin but not ricin via the T3 antigen. Youle RJ; Uckun FM; Vallera DA; Colombatti M J Immunol; 1986 Jan; 136(1):93-8. PubMed ID: 3079613 [TBL] [Abstract][Full Text] [Related]
18. Use of a novel colony assay to evaluate the cytotoxicity of an immunotoxin containing pokeweed antiviral protein against blast progenitor cells freshly obtained from patients with common B-lineage acute lymphoblastic leukemia. Uckun FM; Gajl-Peczalska KJ; Kersey JH; Houston LL; Vallera DA J Exp Med; 1986 Feb; 163(2):347-68. PubMed ID: 3511171 [TBL] [Abstract][Full Text] [Related]
19. Anti-T cell monoclonal antibodies conjugated to ricin as potential reagents for human GVHD prophylaxis: effect on the generation of cytotoxic T cells in both peripheral blood and bone marrow. Quinones RR; Youle RJ; Kersey JH; Zanjani ED; Azemove SM; Soderling CC; Lebien TW; Beverley PC; Neville DM; Vallera DA J Immunol; 1984 Feb; 132(2):678-83. PubMed ID: 6606676 [TBL] [Abstract][Full Text] [Related]
20. An immunotoxin composed of a monoclonal antitransferrin receptor antibody linked by a disulfide bond to the ribosome-inactivating protein gelonin: potent in vitro and in vivo effects against human tumors. Scott CF; Goldmacher VS; Lambert JM; Jackson JV; McIntyre GD J Natl Cancer Inst; 1987 Nov; 79(5):1163-72. PubMed ID: 3500356 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]